162778
BenchMark Dose of Urine Fluorine and Child Skeletal Flurosis
Xinhua Li, MD
,
Department of Preventive Medicine, Guiyang Medical College, Guiyang, Guizhou, China
Xianghui Qin, BM
,
Department of Preventive Medicine, Guiyang Medical College, Guiyang, Guizhou, China
Maojuan Yu, MD
,
Department of Preventive Medicine, Guiyang Medical College, Guiyang, Guizhou, China
Lei Zhang, PhD MBA
,
Bureau of Health Data and Research, Mississippi Department of Health, Jackson, MS
Objective: To identify the BenchMark Dose (BMD) of children urine fluorine in a coal-burning endemic fluorosis region and to investigate the association between urine fluorine level and child skeletal flurosis. Setting: Fluorosis from in-door burning of coal is prevalent in Guizhou province of China. Child skeletal flurosis has greatly affected children's growth and development. Methods: This is a case-control study. Students from five schools in a region with high usage of coal were selected as case group. Students in a school located in the area where residents use least coal were selected as control group. All students aged 7-16 years. The concentration of urine fluorine were measured and grouped into 7 levels. The means of urine fluorine concentration of the case- and control group were compared using ANOVA. For the case group, the association between urine fluorine level and clinical detection rate of skeletal fluorosis was determined using logistic regression. Results: There is a significant difference for the urine fluorine concentrations between the case- and the control group (p<0.05). In the case group, there is a significant dose-response relationship between the urine fluorine level and the clinical detection rate of skeletal fluorosis (F= 65.71, p<0.001). In the case group, BMD is 1.83 mg/L, and the BenchMark Dose lower bound (BMDL) is 1.59 mg/L. Conclusions: Children in the coal-burning region are at a significantly higher risk of skeletal fluorosis, reflected by higher urine fluorine concentration. Close monitoring of children's urine fluorine level is recommended with a BMDL of 1.59 ml/L.
Learning Objectives: At the end of the session, participants will be able to:
(1) Describe the BMD levels for child skeletal fluorosis.
(2) Describe the association between BMD and child skeletal fluorosis.
(3) Understand the case-control study method.
Keywords: Child Health, Environmental Health
Presenting author's disclosure statement:Any relevant financial relationships? Yes
Name of Organization |
Clinical/Research Area |
Type of relationship |
Guiyang Medical College |
Epidemiology |
Employment (includes retainer) |
Any institutionally-contracted trials related to this submission? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|